APO 020 (Omeprazole delayed release 20 mg)
Pill imprint APO 020 has been identified as Omeprazole delayed release 20 mg.
Omeprazole is used in the treatment of gerd; helicobacter pylori infection; barrett's esophagus; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. Risk cannot be ruled out during pregnancy. Omeprazole 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for APO 020
- 20 mg
- Pink / Red
- 18.00 mm
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Apotex Corp.
- National Drug Code (NDC):
- Inactive Ingredients:
- magnesium hydroxide
methacrylic acid - ethyl acrylate copolymer (1:1) type a
ferric oxide red
|NDC Code||Manufacturer / Repackager|
|54569-5482||A S Medication Solutions LLC (repackager)|
|33261-0087||Aidarex Pharmacuticals LLC (repackager)|
|68387-0370||Keltman Pharmaceuticals Inc (repackager)|
|18837-0116||Innoviant Pharmacy Inc (repackager)|
|60429-0157||Golden State Medical Supply (repackager)|
|10544-0341||Blenheim Pharmacal Inc (repackager)|
|55289-0971||PDRX Pharmaceuticals Inc (repackager)|
|66336-0706||Dispensing Solutions Inc. (repackager)|
|21695-0098||Rebel Distributors Corp (repackager)|
|68258-9123||Dispensing Solutions Inc. (repackager)|
|16590-0176||Stat RX USA LLC (repackager)|
|43063-0212||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about omeprazole
- Omeprazole delayed-release capsules
- Omeprazole delayed-release oral suspension
- Omeprazole delayed-release tablets
- Omeprazole magnesium delayed-release capsules and tablets
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.